3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
28
Carcinoma, Non-Small-Cell Lung
15
Squamous Cell Carcinoma of Head and Neck
14
Neoplasms
8
Colonic Neoplasms
7
Pancreatic Neoplasms
6
Neoplasm Metastasis
6
Lung Neoplasms
6
Rectal Neoplasms
5
Mouth Neoplasms
5
Head and Neck Neoplasms
5
Carcinoma, Squamous Cell
4
Carcinoma
4
Laryngeal Neoplasms
3
Hypopharyngeal Neoplasms
3
Thyroid Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Endometrial Neoplasms
2
Breast Neoplasms
2
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Solid Tumors
1
Soft Tissue Neoplasms
1
Skin Neoplasms
1
Sarcoma
1
Recurrence
1
Pharyngeal Neoplasms
1
Neurofibromatosis 2
1
Interventions
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
trastuzumab deruxtecan
2
Cisplatin
2
Biopsy
2
pembrolizumab
1
luprolide acetate gel depot
1
entrectinib
1
dehydroftorafur
1
darolutamide
1
ceralasertib
1
apalutamide
1
amivantamab
1
Surveys and Questionnaires
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Platinum
1
Pemetrexed
1
Leuprolide
1
Immunoglobulin G
1
Gonadotropin-Releasing Hormone
1
Glutamate Carboxypeptidase II
1
Fluorouracil
1
Docetaxel
1
Disulfides
1
Carboplatin
1
Bevacizumab
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Salivary Gland Neoplasms
×
Cetuximab
×
30 days
×
Clear all
No trials found.